Prevalence and predictors of cardiac hypertrophy and dysfunction in patients with Type 2 diabetes

Clinical Science

Volumn 114, Issue 3-4, 2008, Pages 313-320

  Srivastava, Piyush M ^a,b   Calafiore, Paul ^b   MacIsaac, Richard K ^a,c   Patel, Sheila K ^a   Thomas, Merlin C ^a,d   Jerums, George ^a,c   Burrell, Louise M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b AUSTIN HEALTH   (Australia)

^c HEIDELBERG REPATRIATION HOSPITAL   (Australia)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Cardiovascular risk; Echocardiography; Left ventricular hypertrophy; Tissue Doppler imaging; Type 2 diabetes

Indexed keywords

ANTIHYPERTENSIVE AGENT; CREATINE;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; CREATININE CLEARANCE; DIASTOLIC DYSFUNCTION; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASE; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE HYPERTROPHY; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; PRIORITY JOURNAL; RISK; SYSTOLIC DYSFUNCTION; VASCULAR DISEASE; AGING; ANALYSIS OF VARIANCE; CARDIOMEGALY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; ELECTROCARDIOGRAPHY; HEART MUSCLE; KIDNEY; METABOLIC CLEARANCE RATE; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; STATISTICAL MODEL;

AGING; ANALYSIS OF VARIANCE; ANTIHYPERTENSIVE AGENTS; CARDIOMEGALY; CREATINE; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; KIDNEY; LOGISTIC MODELS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; MYOCARDIUM; OBESITY; PREVALENCE;

EID: 38949092309     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20070261     Document Type: Article

References (32)

1. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA, J. Am. Med. Assoc. 285, 2486-2497
2. Fox, C. S., Coady, S., Sorlie, P. D. et al. (2007) Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation 115, 1544-1550
3. Mulnier, H. E., Seaman, H. E., Raleigh, V. S., Soedamah-Muthu, S. S., Colhoun, H. M. and Lawrenson, R. A. (2006) Mortality in people with type 2 diabetes in the UK. Diabetic Med. 23, 516-521
4. Stamler, J., Vaccaro, O., Neaton, J. D. and Wentworth, D. (1993) Diabetes, other risk factors and 12 year cardiovascular mortality for men in the multiple risk factor intervention trial (MRFIT). Diabetes Care 16, 434-444
5. Nichols, G. A., Gullion, C. M., Koro, C. E., Ephross, S. A. and Brown, J. B. (2004) The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care 27, 1879-1884
6. Galderisi, M., Anderson, K. M., Wilson, P. W. and Levy, D. (1991) Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am. J. Cardiol. 68, 85-89
7. Rubier, S., Dlugash, J., Yuceoglu, Y. Z., Kumral, T., Branwood, A. W. and Grishman, A. (1972) New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am. J. Cardiol. 30, 595-602
8. Candido, R., Forbes, J. M., Thomas, M. C. et al. (2003) A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes. Circ. Res. 92, 785-792
9. Zile, M. R. and Brutsaert, D. L. (2002) New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. Circulation 105, 1503-1508
10. Garcia, M. J., Palac, R. T., Malenka, D. J., Terrell, P. and Plehn, J. F. (1999) Color M-mode Doppler flow propagation velocity is a relatively preload-independent index of left ventricular filling. J. Am. Soc. Echocardiogr. 12, 129-137.
11. Redfield, M. M., Jacobsen, S. J., Burnett, Jr, J. C., Mahoney, D. W., Bailey, K. R. and Rodeheffer, R. J. (2003) Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA, J. Am. Med. Assoc. 289, 194-202
12. Khouri, S. J., Maly, G. T., Suh, D. D. and Walsh, T. E. (2004) A practical approach to the echocardiographic evaluation of diastolic function. J. Am. Soc. Echocardiogr. 17, 290-297
13. Srivastava, P., Burrell, L. M. and Calafiore, P. (2005) Lateral versus medial mitral annular tissue doppler in the echocardiographic assessment of diastolic function and filling pressures: which should we use? Eur. J. Echocardiogr. 6, 97-106
14. Srivastava, P. M., Thomas, M. C., Calafiore, P., Macisaac, R. J., Jerums, G. and Burrell, L. M. (2006) Diastolic dysfunction is associated with anaemia in patients with Type II diabetes. Clin. Sci. 110, 109-116
15. Srivastava, P. M., Calafiore, P., MacIsaac, R. J., Hare, D. L., Jerums, G. and Burrell, L. M. (2004) Thiazolidinediones and congestive heart failure-exacerbation or new onset of left ventricular dysfunction? Diabetic Med. 21, 945-950
16. Wang, M., Yip, G. W., Wang, A. Y. et al. (2005) Tissue Doppler imaging provides incremental prognostic value in patients with systemic hypertension and left ventricular hypertrophy. J. Hypertens. 23, 183-191
17. Sanderson, J. E., Wang, M. and Yu, C. M. (2004) Tissue Doppler imaging for predicting outcome in patients with cardiovascular disease. Curr. Opin. Cardiol. 19, 458-463
18. American Diabetes Association (2007) Standards of medical care in diabetes-2007. Diabetes Care 30, S4-S41
19. De Backer, G., Ambrosioni, E., Borch-Johnsen, K. et al. (2004) European Guidelines on Cardiovascular Disease Prevention in Clinical Practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). Atherosclerosis 173, 381-391
20. Candido, R., Srivastava, P., Cooper, M. E. and Burrell, L. M. (2003) Diabetes mellitus: a cardiovascular disease. Curr. Opin. Invest. Drugs 4, 1088-1094
21. Struthers, A. D. and Morris, A. D. (2002) Screening for and treating left-ventricular abnormalities in diabetes mellitus: a new way of reducing cardiac deaths. Lancet 359, 1430-1432
22. Schiller, N. B. (1991) Two-dimensional echocardiographic determination of left ventricular volume, systolic function, and mass. Summary and discussion of the 1989 recommendations of the American Society of Echocardiography. Circulation 84 (Suppl. 3), 1280-1287
23. Fischer, M., Baessler, A., Hense, H. W. et al. (2003) Prevalence of left ventricular diastolic dysfunction in the community: results from a Doppler echocardiographic-based survey of a population sample. Eur. Heart J. 24, 320-328
24. Grossman, E., Shemesh, J., Shamiss, A., Thaler, M., Carroll, J. and Rosenthal, T. (1992) Left ventricular mass in diabetes-hypertension. Arch. Intern. Med. 152, 1001-1004.
25. Kenchaiah, S., Evans, J. C., Levy, D. et al. (2002) Obesity and the risk of heart failure. N. Engl. J. Med. 347, 305-313
26. Frustaci, A., Kajstura, J., Chimenti, C. et al. (2000) Myocardial cell death in human diabetes. Circ. Res. 87, 1123-1132.
27. Kosmala, W., Kucharski, W., Przewlocka-Kosmala, M. and Mazurek, W. (2004) Comparison of left ventricular function by tissue Doppler imaging in patients with diabetes mellitus without systemic hypertension versus diabetes mellitus with systemic hypertension. Am. J. Cardiol. 94, 395-399
28. Liu, J. E., Robbins, D. C., Palmieri, V. et al. (2003) Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: the Strong Heart Study. J. Am. Coll. Cardiol. 41, 2022-2028
29. Whalley, G. A., Doughty, R. N., Gamble, G. D. et al. (2002) Pseudonormal mitral filling pattern predicts hospital re-admission in patients with congestive heart failure. J. Am. Coll. Cardiol. 39, 1787-1795.
30. Lindholm, L. H., Ibsen, H., Dahlof, B. et al. (2002) Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359, 1004-1010
31. Solomon, S., Janardhanan, R., Verma, A. et al. (2007) Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial. Lancet 369, 2079-2087
32. Patel, A. and ADVANCE Collaborative Group (2007) Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes (the ADVANCE trial): a randomised controlled trial. Lancet 370, 829-840